Cryogenic enrichment of Plasmodium falciparum gametocytes from spiked whole blood.

Cryogenic Enrichment Gametocyte Heterogenous sample Plasmodium

Journal

Cryobiology
ISSN: 1090-2392
Titre abrégé: Cryobiology
Pays: Netherlands
ID NLM: 0006252

Informations de publication

Date de publication:
Mar 2024
Historique:
received: 17 08 2023
revised: 22 11 2023
accepted: 25 11 2023
pubmed: 2 12 2023
medline: 2 12 2023
entrez: 1 12 2023
Statut: ppublish

Résumé

Each individual cell type typically requires a unique set of conditions for optimal cryopreservation outcome, which relates to its specific response to cryoprotective agent (CPA) toxicity, osmotic behavior and sensitivity to ice crystallization. Cryopreservation of heterogenous cell populations is therefore exceedingly difficult as it requires separate and often conflicting conditions for each cell type. Conversely, these contrasting conditions could be utilized to favor cryogenic preference of a single cell population within a heterogenous sample, leading to its enrichment by elimination of remaining cells. To establish proof-of-concept for this overall approach, a protocol was developed for the cryogenic enrichment of Plasmodium falciparum gametocytes from whole blood. To accomplish this goal, we evaluated the effects of CPAs and cooling conditions during cryopreservation of whole blood samples spiked with P. falciparum gametocytes. We identified that cooling to -80 °C at a rate of -1 °C/min in the presence of 11 % glycerol selectively favors recovery of gametocytes. This protocol eliminates 95.3 ± 1.7 % of total blood cells and recovers 43.2 ± 6.5 % of parasites, leading to a 19-fold enrichment as assessed by microscopic examination of blood smears. This protocol is tunable, where gametocyte enrichment 900-fold may be feasible, however there is an apparent tradeoff in overall parasite recovery. Although translation of this protocol for point-of-care testing for malaria presents many challenges, the overall approach of cryogenic purification may prove useful for alternative diagnostic applications.

Identifiants

pubmed: 38040049
pii: S0011-2240(23)00309-7
doi: 10.1016/j.cryobiol.2023.104810
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

104810

Subventions

Organisme : NHLBI NIH HHS
ID : R01 HL157803
Pays : United States
Organisme : NIAID NIH HHS
ID : R21 AI137558
Pays : United States
Organisme : NHLBI NIH HHS
ID : R00 HL143149
Pays : United States
Organisme : NIAID NIH HHS
ID : R21 AI163950
Pays : United States
Organisme : NHLBI NIH HHS
ID : K99 HL143149
Pays : United States
Organisme : NIH HHS
ID : R24 OD034189
Pays : United States

Informations de copyright

Copyright © 2023 Elsevier Inc. All rights reserved.

Auteurs

Jenny E Nesbitt (JE)

Center for Engineering in Medicine & Surgery, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, and Shriners Children's Boston, USA.

Justyna J Jaskiewicz (JJ)

Center for Engineering in Medicine & Surgery, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, and Shriners Children's Boston, USA.

Hailey Bean (H)

Center for Engineering in Medicine & Surgery, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, and Shriners Children's Boston, USA.

Mehmet Toner (M)

Center for Engineering in Medicine & Surgery, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, and Shriners Children's Boston, USA.

Shannon N Tessier (SN)

Center for Engineering in Medicine & Surgery, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, and Shriners Children's Boston, USA.

Rebecca D Sandlin (RD)

Center for Engineering in Medicine & Surgery, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, and Shriners Children's Boston, USA. Electronic address: rdsandlin@mgh.harvard.edu.

Classifications MeSH